Strata Skin Sciences, Inc. (NASDAQ:SSKN) has been given a $12.00 price target by equities research analysts at HC Wainwright in a report issued on Friday. The brokerage currently has a “buy” rating on the medical device company’s stock.

SSKN has been the subject of a number of other research reports. Rodman & Renshaw lifted their price target on Strata Skin Sciences from $1.50 to $12.00 and gave the stock a “buy” rating in a report on Tuesday, May 16th. ValuEngine upgraded Strata Skin Sciences from a “strong sell” rating to a “sell” rating in a report on Friday, June 16th.

Shares of Strata Skin Sciences (NASDAQ SSKN) traded down 11.28% during mid-day trading on Friday, reaching $1.73. The company’s stock had a trading volume of 30,685 shares. Strata Skin Sciences has a 52-week low of $1.65 and a 52-week high of $5.40. The firm’s 50 day moving average is $2.07 and its 200-day moving average is $1.80. The company’s market capitalization is $4.03 million.

Strata Skin Sciences (NASDAQ:SSKN) last posted its quarterly earnings results on Thursday, August 10th. The medical device company reported ($0.52) EPS for the quarter, topping analysts’ consensus estimates of ($0.71) by $0.19. Strata Skin Sciences had a negative return on equity of 39.57% and a negative net margin of 18.00%. The business had revenue of $8.70 million during the quarter, compared to analysts’ expectations of $7.98 million. Analysts forecast that Strata Skin Sciences will post ($2.23) EPS for the current year.

ILLEGAL ACTIVITY WARNING: This news story was first reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this news story on another website, it was stolen and reposted in violation of international trademark & copyright laws. The original version of this news story can be read at https://www.thecerbatgem.com/2017/08/13/strata-skin-sciences-inc-nasdaqsskn-given-a-12-00-price-target-by-hc-wainwright-analysts.html.

About Strata Skin Sciences

STRATA Skin Sciences, Inc, formerly MELA Sciences, Inc, is a medical technology company. The Company is engaged in developing and commercializing products for the diagnosis and treatment of dermatological disorders. The Company has three segments: Dermatology Recurring Procedures, Dermatology Procedures Equipment and Dermatology Imaging.

Receive News & Stock Ratings for Strata Skin Sciences Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Strata Skin Sciences Inc. and related stocks with our FREE daily email newsletter.